List of Figures

FIGURE 1 CUSTOM ANTIBODY MARKET 19
FIGURE 2 RESEARCH DESIGN 22
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATIONS AND REGION 25
FIGURE 4 BOTTOM-UP APPROACH 27
FIGURE 5 TOP-DOWN APPROACH 28
FIGURE 6 DATA TRIANGULATION METHODOLOGY 29
FIGURE 7 CUSTOM ANTIBODIES MARKET, BY SERVICE, 2018 VS. 2023 (USD MILLION) 31
FIGURE 8 CUSTOM ANTIBODIES MARKET, BY TYPE, 2018 VS. 2023 (USD MILLION) 32
FIGURE 9 CUSTOM ANTIBODIES MARKET, BY SOURCE, 2018 VS. 2023 (USD MILLION) 33
FIGURE 10 CUSTOM ANTIBODIES MARKET, BY RESEARCH AREA 2018 VS. 2023 (USD MILLION) 33
FIGURE 11 CUSTOM ANTIBODIES MARKET, BY END USER, 2018 VS. 2023 (USD MILLION) 34
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE CUSTOM ANTIBODIES MARKET 35
FIGURE 13 QUALITY CONCERNS OVER CATALOG ANTIBODIES & THE EXPANDING AB THERAPEUTICS PIPELINE TO DRIVE MARKET GROWTH 36
FIGURE 14 US DOMINATED THE CUSTOM ANTIBODIES MARKET IN 2017 37
FIGURE 15 APAC TO REGISTER THE HIGHEST GROWTH RATE DURING
THE FORECAST PERIOD (2018–2023) 38
FIGURE 16 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE BETWEEN
2018 & 2023 39
FIGURE 17 CUSTOM ANTIBODIES MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES 40
FIGURE 18 R&D INVESTMENTS, BY COUNTRY (USD BILLION) 42
FIGURE 19 NUMBER OF THERAPEUTIC ANTIBODIES APPROVED FOR MARKET RELEASE (2011–2017) 43
FIGURE 20 PERSONALIZED MEDICINE PRODUCTS, 2008–2016 45
FIGURE 21 INCREASING FOCUS ON ADCS & THE DEVELOPMENT OF BISPECIFIC ANTIBODIES ARE THE KEY MARKET TRENDS 49
FIGURE 22 ANTIBODY DEVELOPMENT SERVICES TO DOMINATE THE CUSTOM ANTIBODIES MARKET DURING THE FORECAST PERIOD 52
FIGURE 23 RECOMBINANT ANTIBODIES SEGMENT IS EXPECTED TO WITNESS HIGH GROWTH DURING THE FORECAST PERIOD 62
FIGURE 24 ONCOLOGY TO DOMINATE THE CUSTOM ANTIBODIES MARKET DURING THE FORECAST PERIOD 75
FIGURE 25 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE THE CUSTOM ANTIBODIES MARKET DURING THE FORECAST PERIOD 86
FIGURE 26 CUSTOM ANTIBODIES MARKET: GEOGRAPHIC SNAPSHOT (2017) 93
FIGURE 27 NORTH AMERICA: CUSTOM ANTIBODIES MARKET SNAPSHOT 95
FIGURE 28 EUROPE: CUSTOM ANTIBODIES MARKET SNAPSHOT 106
FIGURE 29 ASIA PACIFIC: CUSTOM ANTIBODIES MARKET SNAPSHOT 129
FIGURE 30 EXPANSIONS?KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS FROM 2015 TO OCTOBER 2018 153
FIGURE 31 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT 159
FIGURE 32 GENSCRIPT: COMPANY SNAPSHOT 163
FIGURE 33 ABCAM PLC: COMPANY SNAPSHOT 167
FIGURE 34 MERCK GROUP: COMPANY SNAPSHOT 171
FIGURE 35 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT 175
FIGURE 36 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT 180

 

List of Tables

TABLE 1 MARKET DRIVERS: IMPACT ANALYSIS 44
TABLE 2 MARKET OPPORTUNITIES: IMPACT ANALYSIS 47
TABLE 3 MARKET CHALLENGES: IMPACT ANALYSIS 48
TABLE 4 CUSTOM ANTIBODIES MARKET, BY SERVICE, 2016–2023 (USD MILLION) 52
TABLE 5 ANTIBODY DEVELOPMENT MARKET, BY TYPE, 2016–2023 (USD MILLION) 53
TABLE 6 ANTIBODY DEVELOPMENT MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 54
TABLE 7 ANTIBODY CHARACTERIZATION MARKET, BY COUNTRY 2016–2023 (USD MILLION) 55
TABLE 8 ANTIGEN PREPARATION MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 56
TABLE 9 IMMUNIZATION & HYBRIDOMA PRODUCTION MARKET, BY COUNTRY 2016–2023 (USD MILLION) 58
TABLE 10 ANTIBODY PRODUCTION & PURIFICATION MARKET, BY COUNTRY 2016–2023 (USD MILLION) 59
TABLE 11 ANTIBODY FRAGMENTATION & LABELING MARKET, BY COUNTRY 2016–2023 (USD MILLION) 60
TABLE 12 CUSTOM ANTIBODIES MARKET, BY TYPE, 2016–2023 (USD MILLION) 62
TABLE 13 CUSTOM MONOCLONAL ANTIBODIES MARKET, BY COUNTRY 2016–2023 (USD MILLION) 64
TABLE 14 CUSTOM POLYCLONAL ANTIBODIES MARKET, BY COUNTRY 2016–2023 (USD MILLION) 65
TABLE 15 CUSTOM RECOMBINANT ANTIBODIES MARKET, BY COUNTRY 2016–2023 (USD MILLION) 67
TABLE 16 OTHER CUSTOM ANTIBODIES MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 68
TABLE 17 CUSTOM ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION) 70
TABLE 18 CUSTOM ANTIBODIES MARKET FOR MICE, BY COUNTRY 2016–2023 (USD MILLION) 71
TABLE 19 CUSTOM ANTIBODIES MARKET FOR RABBITS, BY COUNTRY 2016–2023 (USD MILLION) 72
TABLE 20 CUSTOM ANTIBODIES MARKET FOR OTHER SOURCES, BY COUNTRY 2016–2023 (USD MILLION) 73
TABLE 21 CUSTOM ANTIBODIES MARKET, BY RESEARCH AREA, 2016–2023 (USD MILLION) 75
TABLE 22 CUSTOM ANTIBODIES MARKET FOR ONCOLOGY, BY COUNTRY 2016–2023 (USD MILLION) 77
TABLE 23 CUSTOM ANTIBODIES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY 2016–2023 (USD MILLION) 78
TABLE 24 CUSTOM ANTIBODIES MARKET FOR IMMUNOLOGY, BY COUNTRY 2016–2023 (USD MILLION) 79
TABLE 25 CUSTOM ANTIBODIES MARKET FOR NEUROBIOLOGY, BY COUNTRY 2016–2023 (USD MILLION) 81
TABLE 26 CUSTOM ANTIBODIES MARKET FOR STEM CELLS, BY COUNTRY 2016–2023 (USD MILLION) 82
TABLE 27 CUSTOM ANTIBODIES MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2016–2023 (USD MILLION) 83
TABLE 28 CUSTOM ANTIBODIES MARKET FOR OTHER RESEARCH AREAS, BY COUNTRY, 2016–2023 (USD MILLION) 84
TABLE 29 CUSTOM ANTIBODIES MARKET, BY END USER, 2016–2023 (USD MILLION) 86
TABLE 30 CUSTOM ANTIBODIES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2016–2023 (USD MILLION) 88
TABLE 31 CUSTOM ANTIBODIES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2016–2023 (USD MILLION) 90
TABLE 32 CUSTOM ANTIBODIES MARKET FOR CONTRACT RESEARCH ORGANIZATIONS BY COUNTRY, 2016–2023 (USD MILLION) 91
TABLE 33 CUSTOM ANTIBODIES MARKET, BY REGION, 2016–2023 (USD MILLION) 94
TABLE 34 NORTH AMERICA: CUSTOM ANTIBODIES MARKET, BY COUNTRY 2016–2023 (USD MILLION) 96
TABLE 35 NORTH AMERICA: CUSTOM ANTIBODIES MARKET, BY SERVICE 2016–2023 (USD MILLION) 96
TABLE 36 NORTH AMERICA: ANTIBODY DEVELOPMENT MARKET, BY TYPE 2016–2023 (USD MILLION) 96
TABLE 37 NORTH AMERICA: CUSTOM ANTIBODIES MARKET, BY TYPE 2016–2023 (USD MILLION) 97
TABLE 38 NORTH AMERICA: CUSTOM ANTIBODIES MARKET, BY SOURCE 2016–2023 (USD MILLION) 97
TABLE 39 NORTH AMERICA: CUSTOM ANTIBODIES MARKET, BY RESEARCH AREA 2016–2023 (USD MILLION) 98
TABLE 40 NORTH AMERICA: CUSTOM ANTIBODIES MARKET, BY END USER 2016–2023 (USD MILLION) 98
TABLE 41 US: CUSTOM ANTIBODIES MARKET, BY SERVICE, 2016–2023 (USD MILLION) 99
TABLE 42 US: ANTIBODY DEVELOPMENT MARKET, BY TYPE, 2016–2023 (USD MILLION) 100
TABLE 43 US: CUSTOM ANTIBODIES MARKET, BY TYPE, 2016–2023 (USD MILLION) 100
TABLE 44 US: CUSTOM ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION) 100
TABLE 45 US: CUSTOM ANTIBODIES MARKET, BY RESEARCH AREA 2016–2023 (USD MILLION) 101
TABLE 46 US: CUSTOM ANTIBODIES MARKET, BY END USER, 2016–2023 (USD MILLION) 101
TABLE 47 CANADA: CUSTOM ANTIBODIES MARKET, BY SERVICE, 2016–2023 (USD MILLION) 103
TABLE 48 CANADA: ANTIBODY DEVELOPMENT MARKET, BY TYPE 2016–2023 (USD MILLION) 103
TABLE 49 CANADA: CUSTOM ANTIBODIES MARKET, BY TYPE, 2016–2023 (USD MILLION) 103
TABLE 50 CANADA: CUSTOM ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION) 104
TABLE 51 CANADA: CUSTOM ANTIBODIES MARKET, BY RESEARCH AREA 2016–2023 (USD MILLION) 104
TABLE 52 CANADA: CUSTOM ANTIBODIES MARKET, BY END USER 2016–2023 (USD MILLION) 105
TABLE 53 EUROPE: CUSTOM ANTIBODIES MARKET, BY COUNTRY 2016–2023 (USD MILLION) 107
TABLE 54 EUROPE: CUSTOM ANTIBODIES MARKET, BY SERVICE, 2016–2023 (USD MILLION) 107
TABLE 55 EUROPE: ANTIBODY DEVELOPMENT MARKET, BY TYPE 2016–2023 (USD MILLION) 107
TABLE 56 EUROPE: CUSTOM ANTIBODIES MARKET, BY TYPE, 2016–2023 (USD MILLION) 108
TABLE 57 EUROPE: CUSTOM ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION) 108
TABLE 58 EUROPE: CUSTOM ANTIBODIES MARKET, BY RESEARCH AREA 2016–2023 (USD MILLION) 109
TABLE 59 EUROPE: CUSTOM ANTIBODIES MARKET, BY END USER 2016–2023 (USD MILLION) 109
TABLE 60 GERMANY: CUSTOM ANTIBODIES MARKET, BY SERVICE 2016–2023 (USD MILLION) 110
TABLE 61 GERMANY: ANTIBODY DEVELOPMENT MARKET, BY TYPE 2016–2023 (USD MILLION) 111
TABLE 62 GERMANY: CUSTOM ANTIBODIES MARKET, BY TYPE, 2016–2023 (USD MILLION) 111
TABLE 63 GERMANY: CUSTOM ANTIBODIES MARKET, BY SOURCE 2016–2023 (USD MILLION) 111
TABLE 64 GERMANY: CUSTOM ANTIBODIES MARKET, BY RESEARCH AREA 2016–2023 (USD MILLION) 112
TABLE 65 GERMANY: CUSTOM ANTIBODIES MARKET, BY END USER 2016–2023 (USD MILLION) 112
TABLE 66 UK: CUSTOM ANTIBODIES MARKET, BY SERVICE, 2016–2023 (USD MILLION) 113
TABLE 67 UK: ANTIBODY DEVELOPMENT MARKET, BY TYPE, 2016–2023 (USD MILLION) 114
TABLE 68 UK: CUSTOM ANTIBODIES MARKET, BY TYPE, 2016–2023 (USD MILLION) 114
TABLE 69 UK: CUSTOM ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION) 115
TABLE 70 UK: CUSTOM ANTIBODIES MARKET, BY RESEARCH AREA 2016–2023 (USD MILLION) 115
TABLE 71 UK: CUSTOM ANTIBODIES MARKET, BY END USER, 2016–2023 (USD MILLION) 115
TABLE 72 FRANCE: CUSTOM ANTIBODIES MARKET, BY SERVICE, 2016–2023 (USD MILLION) 117
TABLE 73 FRANCE: ANTIBODY DEVELOPMENT MARKET, BY TYPE 2016–2023 (USD MILLION) 117
TABLE 74 FRANCE: CUSTOM ANTIBODIES MARKET, BY TYPE, 2016–2023 (USD MILLION) 117
TABLE 75 FRANCE: CUSTOM ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION) 118
TABLE 76 FRANCE: CUSTOM ANTIBODIES MARKET, BY RESEARCH AREA 2016–2023 (USD MILLION) 118
TABLE 77 FRANCE: CUSTOM ANTIBODIES MARKET, BY END USER 2016–2023 (USD MILLION) 119
TABLE 78 ITALY: CUSTOM ANTIBODIES MARKET, BY SERVICE, 2016–2023 (USD MILLION) 120
TABLE 79 ITALY: ANTIBODY DEVELOPMENT MARKET, BY TYPE, 2016–2023 (USD MILLION) 120
TABLE 80 ITALY: CUSTOM ANTIBODIES MARKET, BY TYPE, 2016–2023 (USD MILLION) 120
TABLE 81 ITALY: CUSTOM ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION) 121
TABLE 82 ITALY: CUSTOM ANTIBODIES MARKET, BY RESEARCH AREA 2016–2023 (USD MILLION) 121
TABLE 83 ITALY: CUSTOM ANTIBODIES MARKET, BY END USER, 2016–2023 (USD MILLION) 122
TABLE 84 SPAIN: CUSTOM ANTIBODIES MARKET, BY SERVICE, 2016–2023 (USD MILLION) 123
TABLE 85 SPAIN: ANTIBODY DEVELOPMENT MARKET, BY TYPE, 2016–2023 (USD MILLION) 123
TABLE 86 SPAIN: CUSTOM ANTIBODIES MARKET, BY TYPE, 2016–2023 (USD MILLION) 123
TABLE 87 SPAIN: CUSTOM ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION) 124
TABLE 88 SPAIN: CUSTOM ANTIBODIES MARKET, BY RESEARCH AREA 2016–2023 (USD MILLION) 124
TABLE 89 SPAIN: CUSTOM ANTIBODIES MARKET, BY END USER, 2016–2023 (USD MILLION) 125
TABLE 90 ROE: CUSTOM ANTIBODIES MARKET, BY SERVICE, 2016–2023 (USD MILLION) 126
TABLE 91 ROE: ANTIBODY DEVELOPMENT MARKET, BY TYPE, 2016–2023 (USD MILLION) 126
TABLE 92 ROE: CUSTOM ANTIBODIES MARKET, BY TYPE, 2016–2023 (USD MILLION) 127
TABLE 93 ROE: CUSTOM ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION) 127
TABLE 94 ROE: CUSTOM ANTIBODIES MARKET, BY RESEARCH AREA 2016–2023 (USD MILLION) 127
TABLE 95 ROE: CUSTOM ANTIBODIES MARKET, BY END USER, 2016–2023 (USD MILLION) 128
TABLE 96 ASIA PACIFIC: CUSTOM ANTIBODIES MARKET, BY COUNTRY 2016–2023 (USD MILLION) 130
TABLE 97 ASIA PACIFIC: CUSTOM ANTIBODIES MARKET, BY SERVICE 2016–2023 (USD MILLION) 130
TABLE 98 ASIA PACIFIC: ANTIBODY DEVELOPMENT MARKET, BY TYPE 2016–2023 (USD MILLION) 130
TABLE 99 ASIA PACIFIC: CUSTOM ANTIBODIES MARKET, BY TYPE 2016–2023 (USD MILLION) 131
TABLE 100 ASIA PACIFIC: CUSTOM ANTIBODIES MARKET, BY SOURCE 2016–2023 (USD MILLION) 131
TABLE 101 ASIA PACIFIC: CUSTOM ANTIBODIES MARKET, BY RESEARCH AREA 2016–2023 (USD MILLION) 132
TABLE 102 ASIA PACIFIC: CUSTOM ANTIBODIES MARKET, BY END USER 2016–2023 (USD MILLION) 132
TABLE 103 JAPAN: CUSTOM ANTIBODIES MARKET, BY SERVICE, 2016–2023 (USD MILLION) 134
TABLE 104 JAPAN: ANTIBODY DEVELOPMENT MARKET, BY TYPE, 2016–2023 (USD MILLION) 134
TABLE 105 JAPAN: CUSTOM ANTIBODIES MARKET, BY TYPE, 2016–2023 (USD MILLION) 134
TABLE 106 JAPAN: CUSTOM ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION) 135
TABLE 107 JAPAN: CUSTOM ANTIBODIES MARKET, BY RESEARCH AREA 2016–2023 (USD MILLION) 135
TABLE 108 JAPAN: CUSTOM ANTIBODIES MARKET, BY END USER, 2016–2023 (USD MILLION) 136
TABLE 109 CHINA: CUSTOM ANTIBODIES MARKET, BY SERVICE, 2016–2023 (USD MILLION) 137
TABLE 110 CHINA: ANTIBODY DEVELOPMENT MARKET, BY TYPE, 2016–2023 (USD MILLION) 137
TABLE 111 CHINA: CUSTOM ANTIBODIES MARKET, BY TYPE, 2016–2023 (USD MILLION) 138
TABLE 112 CHINA: CUSTOM ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION) 138
TABLE 113 CHINA: CUSTOM ANTIBODIES MARKET, BY RESEARCH AREA 2016–2023 (USD MILLION) 138
TABLE 114 CHINA: CUSTOM ANTIBODIES MARKET, BY END USER, 2016–2023 (USD MILLION) 139
TABLE 115 INDIA: CUSTOM ANTIBODIES MARKET, BY SERVICE, 2016–2023 (USD MILLION) 140
TABLE 116 INDIA: ANTIBODY DEVELOPMENT MARKET, BY TYPE, 2016–2023 (USD MILLION) 140
TABLE 117 INDIA: CUSTOM ANTIBODIES MARKET, BY TYPE, 2016–2023 (USD MILLION) 141
TABLE 118 INDIA: CUSTOM ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION) 141
TABLE 119 INDIA: CUSTOM ANTIBODIES MARKET, BY RESEARCH AREA 2016–2023 (USD MILLION) 142
TABLE 120 INDIA: CUSTOM ANTIBODIES MARKET, BY END USER, 2016–2023 (USD MILLION) 142
TABLE 121 ROAPAC: CUSTOM ANTIBODIES MARKET, BY SERVICE, 2016–2023 (USD MILLION) 143
TABLE 122 ROAPAC: ANTIBODY DEVELOPMENT MARKET, BY TYPE 2016–2023 (USD MILLION) 144
TABLE 123 ROAPAC: CUSTOM ANTIBODIES MARKET, BY TYPE, 2016–2023 (USD MILLION) 144
TABLE 124 ROAPAC: CUSTOM ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION) 144
TABLE 125 ROAPAC: CUSTOM ANTIBODIES MARKET, BY RESEARCH AREA 2016–2023 (USD MILLION) 145
TABLE 126 ROAPAC: CUSTOM ANTIBODIES MARKET, BY END USER 2016–2023 (USD MILLION) 145
TABLE 127 LATIN AMERICA: CUSTOM ANTIBODIES MARKET, BY SERVICE 2016–2023 (USD MILLION) 146
TABLE 128 LATIN AMERICA: ANTIBODY DEVELOPMENT MARKET, BY TYPE 2016–2023 (USD MILLION) 147
TABLE 129 LATIN AMERICA: CUSTOM ANTIBODIES MARKET, BY TYPE 2016–2023 (USD MILLION) 147
TABLE 130 LATIN AMERICA: CUSTOM ANTIBODIES MARKET, BY SOURCE 2016–2023 (USD MILLION) 148
TABLE 131 LATIN AMERICA: CUSTOM ANTIBODIES MARKET, BY RESEARCH AREA 2016–2023 (USD MILLION) 148
TABLE 132 LATIN AMERICA: CUSTOM ANTIBODIES MARKET, BY END USER 2016–2023 (USD MILLION) 149
TABLE 133 MIDDLE EAST & AFRICA: CUSTOM ANTIBODIES MARKET, BY SERVICE 2016–2023 (USD MILLION) 150
TABLE 134 MIDDLE EAST & AFRICA: ANTIBODY DEVELOPMENT MARKET, BY TYPE 2016–2023 (USD MILLION) 150
TABLE 135 MIDDLE EAST & AFRICA: CUSTOM ANTIBODIES MARKET, BY TYPE 2016–2023 (USD MILLION) 151
TABLE 136 MIDDLE EAST & AFRICA: CUSTOM ANTIBODIES MARKET, BY SOURCE 2016–2023 (USD MILLION) 151
TABLE 137 MIDDLE EAST & AFRICA: CUSTOM ANTIBODIES MARKET, BY RESEARCH AREA, 2016–2023 (USD MILLION) 152
TABLE 138 MIDDLE EAST & AFRICA: CUSTOM ANTIBODIES MARKET, BY END USER 2016–2023 (USD MILLION) 152
TABLE 139 CUSTOM ANTIBODIES MARKET SHARE, BY KEY PLAYER, 2017 154
TABLE 140 PRODUCT AND SERVICE LAUNCHES, 2015–2018 156
TABLE 141 EXPANSIONS, 2015–2018 156
TABLE 142 ACQUISITIONS, 2015–2018 157
TABLE 143 OTHER STRATEGIES, 2015–2018 158